• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核医学中监测患者的一项新提议。

A new proposal for monitoring patients in nuclear medicine.

作者信息

Willegaignon J, Guimarães Maria I C, Sapienza Marcelo T, Stabin Michael G, Malvestiti Luiz F, Marone Marília, Sordi Gian-Maria A A

机构信息

Radiological Protection Service, Instituto de Pesquisas Energéticas e Nucleares, Av. Prof. Lineu Prestes, 2242, Cidade Universitaria, CEP 05508-000, São Paulo, Brazil.

出版信息

Health Phys. 2006 Dec;91(6):624-9. doi: 10.1097/01.HP.0000225467.10064.34.

DOI:10.1097/01.HP.0000225467.10064.34
PMID:17099406
Abstract

The measurement of exposure rates is fundamentally important in the release of patients given radioactive materials and for keeping the exposures of others as low as reasonable achievable. Similar measurement methodologies have generally been used for point and extended sources, but this approach may lead to methodological errors in calculating radiation dose estimates. In this study, nuclear medicine patients who received high activities of Na131I for therapy were monitored using different measurement methodologies, and the results showed that the usual measurement performed at 1.0 m in front of the body resulted in a mean error of 40% between experimental and theoretical exposure rates. The best measurements were obtained when performed at 2.0 m in front of the patients. With this approach, the error was about 2% between experimental and theoretical values. These findings suggest a new methodology for patients' measurement in nuclear medicine and could be useful for personal monitoring in cases of radiological emergencies involving 131I ingestion.

摘要

在给予放射性物质的患者出院时,以及为使其他人的暴露尽可能低至合理可行水平,暴露率的测量至关重要。对于点源和扩展源,通常采用类似的测量方法,但这种方法在计算辐射剂量估计值时可能会导致方法误差。在本研究中,使用不同的测量方法对接受高活度Na131I治疗的核医学患者进行了监测,结果表明,通常在身体前方1.0米处进行的测量导致实验暴露率与理论暴露率之间的平均误差为40%。在患者前方2.0米处进行测量时,得到了最佳结果。采用这种方法,实验值与理论值之间的误差约为2%。这些发现提示了一种核医学患者测量的新方法,并且在涉及摄入131I的放射紧急情况中进行个人监测时可能会有用。

相似文献

1
A new proposal for monitoring patients in nuclear medicine.核医学中监测患者的一项新提议。
Health Phys. 2006 Dec;91(6):624-9. doi: 10.1097/01.HP.0000225467.10064.34.
2
Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.用于更准确估计放射性患者附近暴露率的校正因子:实验、点源和线源模型。
Health Phys. 2007 Dec;93(6):678-88. doi: 10.1097/01.HP.0000275298.69543.5c.
3
Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.接受¹³¹I治疗的甲亢和甲状腺癌患者家庭成员所受的辐射剂量。
Radiat Prot Dosimetry. 2006;118(1):22-7. doi: 10.1093/rpd/nci337. Epub 2005 Aug 16.
4
Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.甲状腺癌治疗中¹³¹I治疗的患者参数及其他辐射安全问题。
Health Phys. 2007 Dec;93(6):656-66. doi: 10.1097/01.HP.0000270274.66246.7e.
5
Hospital discharge of patients with thyroid carcinoma treated with 131I.接受¹³¹I治疗的甲状腺癌患者出院情况。
J Nucl Med. 2002 Jan;43(1):61-5.
6
131I effective half-life (Teff) for patients with thyroid cancer.甲状腺癌患者的131I有效半衰期(Teff)。
Health Phys. 2006 Aug;91(2):119-22. doi: 10.1097/01.HP.0000202232.98823.87.
7
The evaluation of the external dose measurement of the patients treated with radioiodine therapy.放射性碘治疗患者的外照射剂量测量评估。
Radiat Prot Dosimetry. 2010 Oct;141(3):233-8. doi: 10.1093/rpd/ncq179. Epub 2010 Jul 11.
8
A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers.一种用于自动监测核医学工作者体内¹³¹I污染的方法。
Radiat Prot Dosimetry. 2007;125(1-4):483-7. doi: 10.1093/rpd/ncm151. Epub 2007 Aug 31.
9
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?门诊使用3.7和5.55GBq的碘化钠(¹³¹I)治疗分化型甲状腺癌是否安全?
Nucl Med Commun. 2009 Jul;30(7):533-41. doi: 10.1097/MNM.0b013e32832b79bc.
10
Radiation safety considerations for post-iodine-131 thyroid cancer therapy.
J Nucl Med. 1992 Jul;33(7):1402-5.

引用本文的文献

1
Radiation safety measures in diagnostic nuclear medicine, based on the potential radiation dose emitted by radioactive patients.基于放射性患者所发射的潜在辐射剂量的诊断核医学中的辐射安全措施。
Radiol Bras. 2023 Jan-Feb;56(1):13-20. doi: 10.1590/0100-3984.2022.0064.
2
Radiation safety issues in y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients.钇-90微球选择性肝动脉放射性栓塞治疗中的辐射安全问题:患者可能受到的辐射暴露
Nucl Med Mol Imaging. 2010 Dec;44(4):252-60. doi: 10.1007/s13139-010-0047-7. Epub 2010 Aug 25.